Skip to main content

ORIGINAL RESEARCH article

Front. Mater.
Sec. Ceramics and Glass
Volume 11 - 2024 | doi: 10.3389/fmats.2024.1376854

Osteomyelitis affected bone regeneration studies of Linezolid combined Strontium substituted hydroxyapatite-Bi polymeric composite Provisionally Accepted

Hua Li1 Qi Du2 Pei-Yu Guo1 Yong-Tao Yi1  Xi Li1*
  • 1The First Affiliated Hospital of Kunming Medical University, China
  • 2Kunming Medical University, China

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

The primary objective of the investigation is to rectify bacterial infections in bone (Osteomyelitis) and bone regeneration by utilizing antibiotic-loaded hydroxyapatite polymer composite. In this regard, the strontium (Sr) -substituted hydroxyapatite (mHAP) reinforced polymeric composites with linezolid (LNZ) were utilized for osteomyelitis-affected bone repair. The brittle nature of the mHAP ceramic has been overcome by reinforcing the polymers such as polyvinyl pyrrolidone (PVP) and poly(sodium 4-styrene sulfonate) (PSSS). The composite formation, crystallinity, surface morphology, and zeta potentials were investigated through FTIR, XRD, SEM, TEM, and DLS techniques. The particle size and zeta potential were observed and the zeta potential value of mHAP/PVP-PSSS and mHAP/PVP-PSSS/LNZ composites are -14.8 mV and -40.3 mV, respectively. The bioactive results with SBF are favorable for apatite formation and confirm the composite's biocompatible to new bone formation.The cell viability of human bone marrow mesenchymal stem cells (hBMSCs) and the gene expression analysis confirmed the osteogenesis potential of the prepared materials. Since the prepared composite has obtained potential results, these studies confirm that the prepared composite can release the antibiotic for the treatment of osteomyelitis-affected bone repair.

Keywords: biomedical, hydroxyapatite, linezolid, Osteomyelitis, Polyvinyl pyrrolidone, Poly(sodium 4-styrene sulfonate)

Received: 26 Jan 2024; Accepted: 09 May 2024.

Copyright: © 2024 Li, Du, Guo, Yi and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mx. Xi Li, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan Province, China